Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers
Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and comp...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Harrison, Stephen A. [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2020 |
|---|
| Übergeordnetes Werk: |
Enthalten in: Quality properties and antioxidant activity of seven strawberry ( - Chaves, Vitor C. ELSEVIER, 2017, design, methods and analysis, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:97 ; year:2020 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.cct.2020.106174 |
|---|
| Katalog-ID: |
ELV052125661 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV052125661 | ||
| 003 | DE-627 | ||
| 005 | 20230624182343.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210910s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.cct.2020.106174 |2 doi | |
| 028 | 5 | 2 | |a /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001209.pica |
| 035 | |a (DE-627)ELV052125661 | ||
| 035 | |a (ELSEVIER)S1551-7144(20)30252-4 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 630 |a 640 |q VZ |
| 084 | |a 48.50 |2 bkl | ||
| 100 | 1 | |a Harrison, Stephen A. |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers |
| 264 | 1 | |c 2020 | |
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and compare the relationship of patient characteristics and non-invasive biomarkers/scores. | ||
| 700 | 1 | |a Calanna, Salvatore |4 oth | |
| 700 | 1 | |a Cusi, Kenneth |4 oth | |
| 700 | 1 | |a Linder, Martin |4 oth | |
| 700 | 1 | |a Okanoue, Takeshi |4 oth | |
| 700 | 1 | |a Ratziu, Vlad |4 oth | |
| 700 | 1 | |a Sanyal, Arun |4 oth | |
| 700 | 1 | |a Sejling, Anne-Sophie |4 oth | |
| 700 | 1 | |a Newsome, Philip N. |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier Science |a Chaves, Vitor C. ELSEVIER |t Quality properties and antioxidant activity of seven strawberry ( |d 2017 |d design, methods and analysis |g Amsterdam [u.a.] |w (DE-627)ELV000409197 |
| 773 | 1 | 8 | |g volume:97 |g year:2020 |g pages:0 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.cct.2020.106174 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 48.50 |j Pflanzenproduktion: Allgemeines |q VZ |
| 951 | |a AR | ||
| 952 | |d 97 |j 2020 |h 0 | ||
| author_variant |
s a h sa sah |
|---|---|
| matchkey_str |
harrisonstephenacalannasalvatorecusikenn:2020----:ealtdfrhtetetfoachlctaoeaiitileinncma |
| hierarchy_sort_str |
2020 |
| bklnumber |
48.50 |
| publishDate |
2020 |
| allfields |
10.1016/j.cct.2020.106174 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001209.pica (DE-627)ELV052125661 (ELSEVIER)S1551-7144(20)30252-4 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.50 bkl Harrison, Stephen A. verfasserin aut Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and compare the relationship of patient characteristics and non-invasive biomarkers/scores. Calanna, Salvatore oth Cusi, Kenneth oth Linder, Martin oth Okanoue, Takeshi oth Ratziu, Vlad oth Sanyal, Arun oth Sejling, Anne-Sophie oth Newsome, Philip N. oth Enthalten in Elsevier Science Chaves, Vitor C. ELSEVIER Quality properties and antioxidant activity of seven strawberry ( 2017 design, methods and analysis Amsterdam [u.a.] (DE-627)ELV000409197 volume:97 year:2020 pages:0 https://doi.org/10.1016/j.cct.2020.106174 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 48.50 Pflanzenproduktion: Allgemeines VZ AR 97 2020 0 |
| spelling |
10.1016/j.cct.2020.106174 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001209.pica (DE-627)ELV052125661 (ELSEVIER)S1551-7144(20)30252-4 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.50 bkl Harrison, Stephen A. verfasserin aut Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and compare the relationship of patient characteristics and non-invasive biomarkers/scores. Calanna, Salvatore oth Cusi, Kenneth oth Linder, Martin oth Okanoue, Takeshi oth Ratziu, Vlad oth Sanyal, Arun oth Sejling, Anne-Sophie oth Newsome, Philip N. oth Enthalten in Elsevier Science Chaves, Vitor C. ELSEVIER Quality properties and antioxidant activity of seven strawberry ( 2017 design, methods and analysis Amsterdam [u.a.] (DE-627)ELV000409197 volume:97 year:2020 pages:0 https://doi.org/10.1016/j.cct.2020.106174 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 48.50 Pflanzenproduktion: Allgemeines VZ AR 97 2020 0 |
| allfields_unstemmed |
10.1016/j.cct.2020.106174 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001209.pica (DE-627)ELV052125661 (ELSEVIER)S1551-7144(20)30252-4 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.50 bkl Harrison, Stephen A. verfasserin aut Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and compare the relationship of patient characteristics and non-invasive biomarkers/scores. Calanna, Salvatore oth Cusi, Kenneth oth Linder, Martin oth Okanoue, Takeshi oth Ratziu, Vlad oth Sanyal, Arun oth Sejling, Anne-Sophie oth Newsome, Philip N. oth Enthalten in Elsevier Science Chaves, Vitor C. ELSEVIER Quality properties and antioxidant activity of seven strawberry ( 2017 design, methods and analysis Amsterdam [u.a.] (DE-627)ELV000409197 volume:97 year:2020 pages:0 https://doi.org/10.1016/j.cct.2020.106174 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 48.50 Pflanzenproduktion: Allgemeines VZ AR 97 2020 0 |
| allfieldsGer |
10.1016/j.cct.2020.106174 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001209.pica (DE-627)ELV052125661 (ELSEVIER)S1551-7144(20)30252-4 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.50 bkl Harrison, Stephen A. verfasserin aut Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and compare the relationship of patient characteristics and non-invasive biomarkers/scores. Calanna, Salvatore oth Cusi, Kenneth oth Linder, Martin oth Okanoue, Takeshi oth Ratziu, Vlad oth Sanyal, Arun oth Sejling, Anne-Sophie oth Newsome, Philip N. oth Enthalten in Elsevier Science Chaves, Vitor C. ELSEVIER Quality properties and antioxidant activity of seven strawberry ( 2017 design, methods and analysis Amsterdam [u.a.] (DE-627)ELV000409197 volume:97 year:2020 pages:0 https://doi.org/10.1016/j.cct.2020.106174 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 48.50 Pflanzenproduktion: Allgemeines VZ AR 97 2020 0 |
| allfieldsSound |
10.1016/j.cct.2020.106174 doi /cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001209.pica (DE-627)ELV052125661 (ELSEVIER)S1551-7144(20)30252-4 DE-627 ger DE-627 rakwb eng 630 640 VZ 48.50 bkl Harrison, Stephen A. verfasserin aut Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers 2020 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and compare the relationship of patient characteristics and non-invasive biomarkers/scores. Calanna, Salvatore oth Cusi, Kenneth oth Linder, Martin oth Okanoue, Takeshi oth Ratziu, Vlad oth Sanyal, Arun oth Sejling, Anne-Sophie oth Newsome, Philip N. oth Enthalten in Elsevier Science Chaves, Vitor C. ELSEVIER Quality properties and antioxidant activity of seven strawberry ( 2017 design, methods and analysis Amsterdam [u.a.] (DE-627)ELV000409197 volume:97 year:2020 pages:0 https://doi.org/10.1016/j.cct.2020.106174 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 48.50 Pflanzenproduktion: Allgemeines VZ AR 97 2020 0 |
| language |
English |
| source |
Enthalten in Quality properties and antioxidant activity of seven strawberry ( Amsterdam [u.a.] volume:97 year:2020 pages:0 |
| sourceStr |
Enthalten in Quality properties and antioxidant activity of seven strawberry ( Amsterdam [u.a.] volume:97 year:2020 pages:0 |
| format_phy_str_mv |
Article |
| bklname |
Pflanzenproduktion: Allgemeines |
| institution |
findex.gbv.de |
| dewey-raw |
630 |
| isfreeaccess_bool |
false |
| container_title |
Quality properties and antioxidant activity of seven strawberry ( |
| authorswithroles_txt_mv |
Harrison, Stephen A. @@aut@@ Calanna, Salvatore @@oth@@ Cusi, Kenneth @@oth@@ Linder, Martin @@oth@@ Okanoue, Takeshi @@oth@@ Ratziu, Vlad @@oth@@ Sanyal, Arun @@oth@@ Sejling, Anne-Sophie @@oth@@ Newsome, Philip N. @@oth@@ |
| publishDateDaySort_date |
2020-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000409197 |
| dewey-sort |
3630 |
| id |
ELV052125661 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV052125661</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624182343.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cct.2020.106174</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001209.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV052125661</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1551-7144(20)30252-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">48.50</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Harrison, Stephen A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and compare the relationship of patient characteristics and non-invasive biomarkers/scores.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calanna, Salvatore</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cusi, Kenneth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Linder, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Okanoue, Takeshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ratziu, Vlad</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sanyal, Arun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sejling, Anne-Sophie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Newsome, Philip N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Chaves, Vitor C. ELSEVIER</subfield><subfield code="t">Quality properties and antioxidant activity of seven strawberry (</subfield><subfield code="d">2017</subfield><subfield code="d">design, methods and analysis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000409197</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:97</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cct.2020.106174</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">48.50</subfield><subfield code="j">Pflanzenproduktion: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">97</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| author |
Harrison, Stephen A. |
| spellingShingle |
Harrison, Stephen A. ddc 630 bkl 48.50 Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers |
| authorStr |
Harrison, Stephen A. |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000409197 |
| format |
electronic Article |
| dewey-ones |
630 - Agriculture & related technologies 640 - Home & family management |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
630 640 VZ 48.50 bkl Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers |
| topic |
ddc 630 bkl 48.50 |
| topic_unstemmed |
ddc 630 bkl 48.50 |
| topic_browse |
ddc 630 bkl 48.50 |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
s c sc k c kc m l ml t o to v r vr a s as a s s ass p n n pn pnn |
| hierarchy_parent_title |
Quality properties and antioxidant activity of seven strawberry ( |
| hierarchy_parent_id |
ELV000409197 |
| dewey-tens |
630 - Agriculture 640 - Home & family management |
| hierarchy_top_title |
Quality properties and antioxidant activity of seven strawberry ( |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000409197 |
| title |
Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers |
| ctrlnum |
(DE-627)ELV052125661 (ELSEVIER)S1551-7144(20)30252-4 |
| title_full |
Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers |
| author_sort |
Harrison, Stephen A. |
| journal |
Quality properties and antioxidant activity of seven strawberry ( |
| journalStr |
Quality properties and antioxidant activity of seven strawberry ( |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2020 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Harrison, Stephen A. |
| container_volume |
97 |
| class |
630 640 VZ 48.50 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Harrison, Stephen A. |
| doi_str_mv |
10.1016/j.cct.2020.106174 |
| dewey-full |
630 640 |
| title_sort |
semaglutide for the treatment of non-alcoholic steatohepatitis: trial design and comparison of non-invasive biomarkers |
| title_auth |
Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers |
| abstract |
Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and compare the relationship of patient characteristics and non-invasive biomarkers/scores. |
| abstractGer |
Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and compare the relationship of patient characteristics and non-invasive biomarkers/scores. |
| abstract_unstemmed |
Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and compare the relationship of patient characteristics and non-invasive biomarkers/scores. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers |
| url |
https://doi.org/10.1016/j.cct.2020.106174 |
| remote_bool |
true |
| author2 |
Calanna, Salvatore Cusi, Kenneth Linder, Martin Okanoue, Takeshi Ratziu, Vlad Sanyal, Arun Sejling, Anne-Sophie Newsome, Philip N. |
| author2Str |
Calanna, Salvatore Cusi, Kenneth Linder, Martin Okanoue, Takeshi Ratziu, Vlad Sanyal, Arun Sejling, Anne-Sophie Newsome, Philip N. |
| ppnlink |
ELV000409197 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.cct.2020.106174 |
| up_date |
2024-07-06T22:10:17.950Z |
| _version_ |
1803869296211787776 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV052125661</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624182343.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">210910s2020 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.cct.2020.106174</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">/cbs_pica/cbs_olc/import_discovery/elsevier/einzuspielen/GBV00000000001209.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV052125661</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1551-7144(20)30252-4</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">630</subfield><subfield code="a">640</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">48.50</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Harrison, Stephen A.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Semaglutide for the treatment of non-alcoholic steatohepatitis: Trial design and comparison of non-invasive biomarkers</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2020</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Non-alcoholic steatohepatitis (NASH) is a chronic liver disease. There is a clear need to develop pharmacological treatment for patients with NASH as well as biomarkers that can diagnose the disease. We describe a trial of semaglutide treatment for NASH, identify key patient characteristics and compare the relationship of patient characteristics and non-invasive biomarkers/scores.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Calanna, Salvatore</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Cusi, Kenneth</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Linder, Martin</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Okanoue, Takeshi</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ratziu, Vlad</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sanyal, Arun</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sejling, Anne-Sophie</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Newsome, Philip N.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier Science</subfield><subfield code="a">Chaves, Vitor C. ELSEVIER</subfield><subfield code="t">Quality properties and antioxidant activity of seven strawberry (</subfield><subfield code="d">2017</subfield><subfield code="d">design, methods and analysis</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000409197</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:97</subfield><subfield code="g">year:2020</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.cct.2020.106174</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">48.50</subfield><subfield code="j">Pflanzenproduktion: Allgemeines</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">97</subfield><subfield code="j">2020</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.401473 |